Dashboard
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 3.40% and Operating profit at 39.20% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 3.33 times
- The company has been able to generate a Return on Equity (avg) of 4.10% signifying low profitability per unit of shareholders funds
The company has declared Positive results for the last 3 consecutive quarters
Stock is technically in a Mildly Bullish range
With ROE of 20.5, it has a Attractive valuation with a 1 Price to Book Value
Majority shareholders : Non Institution
Below par performance in long term as well as near term
Stock DNA
Healthcare Services
INR 188 Cr (Micro Cap)
5.00
16
0.00%
3.61
20.52%
1.07
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Sep-20-2012
Risk Adjusted Returns v/s 
Returns Beta
News

Bilcare Ltd is Rated Hold by MarketsMOJO
Bilcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Bilcare Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
At Rs 88.65, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5% on 16 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Bilcare Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent
At Rs 84.43, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5.0% on 13 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSEBilcare Limited the exchange about the Newspaper Publication of Un-Audited (Standalone and Consolidated) Financial Results for quarter and half ended 30 September 2026
Results - Financial Results For September 30 2026
03-Nov-2026 | Source : BSEThe Board of Directors has approved the Financial Results for quarter and half year ended September 30 2026
Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2026 Along With Limited Review Reports And Change In Designation And Roles
03-Nov-2026 | Source : BSEThe Board of Directors of Bilcare Limited in their meeting held on Tuesday 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial Results of the Company for the period ended on 30 September 2026 and Limited Review Report issued by the Statutory Auditors of the Company and Change in Designation and Roles
Corporate Actions 
No Upcoming Board Meetings
Bilcare Ltd has declared 20% dividend, ex-date: 20 Sep 12
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
1.3868
Held by 0 Schemes
Held by 1 FIIs (0.04%)
Mohan Harakchand Bhandari (24.87%)
Monument Pte Limited (16.44%)
45.33%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 9.99% vs 20.36% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -67.56% vs -5.01% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -7.91% vs 6.37% in Sep 2024
Growth in half year ended Sep 2025 is 27.92% vs -44.74% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -8.10% vs 8.57% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 48.65% vs -32.41% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -100.00% vs 5.47% in Mar 2025
YoY Growth in year ended Mar 2026 is 329.33% vs 97.74% in Mar 2025